Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07288463 · ClinicalTrials.gov registry record · NA
Hearing Loss and Brain Health Study
A NA study, sponsored by University of Southern California.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07288463 is a NA study that has not yet begun recruiting, run by University of Southern California. The registered enrollment target is 40 participants.
The verdict
NCT07288463, a NA study, has not yet begun recruiting, sponsored by University of Southern California.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Hearing loss is a prevalent and modifiable risk factor for cognitive decline and dementia in older adults, yet access to hearing care remains limited. Over-the-counter (OTC) hearing aids represent a promising and scalable strategy to expand access, particularly for individuals at elevated risk for dementia who may benefit most from earlier intervention. This pilot study aims to evaluate the feasibility and acceptability of OTC hearing aid use among older adults. Participants aged ≥50 years will undergo standardized hearing screening to identify bilateral, mild-to-moderate hearing loss. Eligible participants will be randomized to one of two sequences: (1) immediate intervention: 3-mo using OTC hearing aids or (2) waitlist control: 3-mo without devices followed by OTC hearing aid use after 3 months. Feasibility outcomes include study enrollment and retention, protocol adherence, and average daily device use determined by data-logging. Acceptability outcomes will be assessed using the International Outcome Inventory for Hearing Aids (IOI-HA), device satisfaction ratings, and participant intention to continue hearing-aid use. Hearing outcomes include validated questionnaires on hearing and listening efforts. Findings will inform the design of larger trials aimed at improving access to hearing care and promoting cognitive health.
Interventions
- DEVICE Over-The-Counter (OTC) hearing aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2027-07-01 |
| Est. Completion | 2031-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07288463
The ClinicalTrials.gov registry entry for NCT07288463 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Over-The-Counter (OTC) hearing aid is the first listed.
NCT07288463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07288463 about?
NCT07288463 is a clinical study titled "Hearing Loss and Brain Health Study". Hearing loss is a prevalent and modifiable risk factor for cognitive decline and dementia in older adults, yet access to hearing care remains limited. Over-the-counter (OTC) hearing aids represent a promising and scalable strategy to expand access, particularly for individuals at elevated risk for d...
What is the current status of trial NCT07288463?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2027-07-01. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07288463?
The interventions under investigation include: Over-The-Counter (OTC) hearing aid (DEVICE).
Who is sponsoring clinical trial NCT07288463?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.